Indian indices closed lower Tuesday, with investors cautious ahead of the US Federal Reserve's rate decision. Vedanta, ITC, and Piramal Pharma saw notable price action. Analysts suggest Vedanta and ITC are good long-term buys, while Piramal Pharma shows potential for further upside after a recent correction.
